Numakura, K., Muto, Y., Yamamoto, R., Koizumi, A., Nara, T., Kanda, S., Saito, M., Narita, S., Inoue, T., Habuchi, T. (2020) Robotic-assisted laparoscopic partial nephrectomy for renal cell carcinoma in horseshoe kidney: a hybrid technique with conventional laparoscopic surgery. Int. Cancer Conf. J., 9(4), 199-202.
Yamamoto, R., Saito, M., Saito, T., Sagehashi, R., Koizumi, A., Nara, T., Kanda, S., Numakura, K., Narita, S., Inoue, T., Satoh, S., Habuchi, T. (2020) Treg expansion with trichostatin A ameliorates kidney ischemia/reperfusion injury in mice by suppressing the expression of costimulatory molecules. Transpl. Immunol., 63, 101330.
Tanaka, T., Hatakeyama, S., Numakura, K., Kido, K., Noro,D., Oikawa, M., Hosogoe, S., Tokui, N., Yamamoto, H., Narita, S., Ito, H., Yoneyama, T., Hashimoto, Y., Kawaguchi, T., Habuchi, T., Ohyama, C. (2020) Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study. Int. J. Urol., 27(12), 1095-1100.
Chen, J., Liu, X., Ke, K., Zou, J., Gao, Z., Habuchi, T., Yang, X. (2020) LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression. BMC Cancer, 20(1), 749.
Matsumoto, H., Shiraishi, K., Azuma, H., Inoue, K., Uemura, H., Eto, M., Ohyama, C., Ogawa, O., Kikuchi, E., Kitamura, H., Shinohara, N., Takahashi, S., Tsuzuki, T., Nakagawa, M., Narumi, Y., Nishiyama, H., Habuchi, T., Hinotsu, S., Fujii, Y., Fujimoto, K., Fujimoto, H., Mizowaki, T., Matsuyama, H. (2020) Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision. Int. J. Urol., 27(9), 702-709.
Kisou, Y., Inoue, T., Nishijima, K., Huang, M., Yamamoto, R., Koizumi, A., Nara, T., Numakura, K., Saito, M., Narita, S., Satoh, S., Habuchi, T. (2020) Candidate genes involved in the defunctionalization and refunctionalization of the urinary bladder induced by bladder anuria and reperfusion. Neurourol. Urodyn., 39(6), 1653-1666.
Hatakeyama, S., Narita, S., Takahashi, M., Sakurai, T., Kawamura, S., Hoshi, S., Ishida, M., Kawaguchi, T., Ishidoya, S., Shimoda, J., Sato, H., Hamano, I., Okamoto, T., Mitsuzuka, K., Ito, A., Tsuchiya, N., Arai, Y., Habuchi, T., Ohyama, C. (2020) Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study. Int. J. Urol., 27(7), 610-617.
Numakura, K., Kobayashi, M., Hatakeyama, S., Naito, S., Horikawa, Y., Tanaka, T., Kamada, S., Muto, Y., Yamamoto, R., Koizumi, A., Nara, T., Kanda, S., Saito, M., Narita, S., Inoue, T., Shimoda, N., Tsuchiya, N., Ohyama. C., Habuchi, T. (2020) Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes. Int. J. Clin. Oncol., 25(8), 1543-1550.
Sato, H., Narita, S., Saito, M., Yamamoto, R., Koizumi, A., Nara, T., Kanda, S., Numakura, K., Inoue, T., Satoh, S., Abe, K., Habuchi, T. (2020) Acute Kidney Injury and Its Impact on Renal Prognosis after Robot-Assisted Laparoscopic Radical Prostatectomy. Int. J. Med. Robot, 16(5), 1-7.
Matsuda, Y., Narita, S., Nara, T., Mingguo, H., Sato, H., Koizumi, A., Kanda, S., Numakura, K., Saito, M., Inoue, T., Hiroshima, Y., Nanjo, H., Satoh, S., Tsuchiya, N., Habuchi, T. (2020) Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer. BMC Cancer, 20(1), 302.
Kashima, S., Maeda, T., Masuda, K., Nagano, S., Inoue, T., Takeda, M., Kono, Y., Kobayashi, T., Saito, S., Higuchi, T., Ichise, H., Kobayashi, Y., Iwaisako, K., Terada, K., Agata, Y., Numakura, K., Saito, M., Narita, S., Yasukawa, M., Ogawa, O., Habuchi. T,, Kawamoto, H. (2020) Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model. iScience, 23(4), 100998.
Matsuda, Y., Inoue, T., Maeno, A., Koizumi, A., Yamamoto, R., Nara, T., Kanda, S., Numakura, K., Saito, M., Narita, S., Satoh, S., Habuchi, T. (2020) A patient with synchronous bilateral low-grade upper tract urothelial carcinoma who underwent nephroureterectomy and total ureterectomy with ileal ureteric replacement. Int. Cancer Conf. J., 9(2), 82-87.
Sato, S., Akamine, Y., Kagaya, H., Saito, M., Inoue, T., Numakura, K., Habuchi, T., Satoh, S., Miura, M. (2020) Changes in PCSK9 and LDL cholesterol concentrations by everolimus treatment and their effects on polymorphisms in PCSK9 and mTORC1. Pharmacol Rep., 72(3), 622-630.
Numakura, K., Muto, Y., Saito, M., Narita, S., Inoue, T., Habuchi, T. (2020) Robot-assisted laparoscopic pyeloplasty for ureteropelvic junction obstruction with duplex system. Urol. Case Rep., 30, 101138.
Takai, E., Maeda, D., Li, Z., Kudo-Asabe, Y., Totoki, Y., Nakamura, H., Nakamura, A., Nakamura, R., Kirikawa, M., Ito, Y., Yoshida, M., Inoue, T., Habuchi, T., Ikoma, S., Katoh. H., Kato. M., Shibata, T., Ishikawa, S., Yachida, S., Goto, A. (2020) Post-mortem Plasma Cell-Free DNA Sequencing: Proof-of-Concept Study for the "Liquid Autopsy." Sci. Rep., 10(1), 2120.
Narita, S., Hatakeyama, S., Takahashi, M., Sakurai, T., Kawamura, S., Hoshi, S., Ishida, M., Kawaguchi, T., Ishidoya, S., Shimoda, J., Sato, H., Koizumi, A., Mitsuzuka, K., Tochigi, T., Tsuchiya, N., Ohyama, C., Arai, Y., Nomura, K., Habuchi, T. (2020) Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan. Int. J. Clin. Oncol., 25(5), 912-920.
Yokomizo, A., Wakabayashi, M., Satoh, T., Hashine, K., Inoue, T., Fujimoto, K., Egawa, S., Habuchi, T., Kawashima, K., Ishizuka, O., Shinohara, N., Sugimoto, M., Yoshino, Y., Nihei, K., Fukuda, H., Tobisu, K., Kakehi, Y., Naito, S. (2020) Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401). Eur. Urol., 77(6), 689-698.
Okita, K., Hatakeyama, S., Narita, S., Takahashi, M., Sakurai, T., Kawamura, S., Hoshi, S., Ishida, M., Kawaguchi, T., Ishidoya, S., Shimoda, J., Sato, H., Mitsuzuka, K., Ito, A., Tsuchiya, N., Arai, Y., Habuchi, T., Ohyama, C. (2020) The Effect of Treatment Sequence on Overall Survival for Men with Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study. Clin. Genitourin Cancer, 18(2), 103-111.
Okamoto, T., Hatakeyama, S., Narita, S., Arai, Y., Habuchi, T., Ohyama, C. (2020) Validation and development of the CHAARTED criteria in patients with hormone-naïve metastatic prostate cancer: A multi-institutional retrospective study in Japan. Int. J. Urol., 27(1), 90-91.
Inoue, T., Miura, M., Yanishi, M., Furukawa, J., Sato, F., Nitta, M., Yoshimura, K., Hagiuda, J., Shinoda, K., Kobayashi, T., Miyajima, A., Nakagawa, K., Oya, M., Ogawa, O., Mimata, H., Kanayama, H., Fujisawa, M., Terachi, T., Matsuda, T., Habuchi, T. (2020) A comparison of laparoendoscopic single-site surgery versus conventional procedures for laparoscopic donor nephrectomy: a Japanese multi-institutional retrospective study. Surg. Endosc., 34, 3424-3434.
Terada, N., Mizowaki, T., Saito, T., Yokomizo, A., Kohei, N., Tabata, K., Shiota, M., A Takahashi, A., Shimazui, T., Goto, T,. Hashimoto, Y., Fujii, M., Tomida, R., Sakurai, T., Hashimoto, K., Kawamura, S., Teraoka, S., Sakamoto, S., Kimura, K., Kamiyama, M., Narita, S., Tanaka, N., Kato, T., Kato, M., Osawa, T., Kojima, T., Inoue, T., Sugimoto, M., Nishiyama, H., Kamoto, T. (2020) Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer. BJUI Compass, 1(5), 165-173.
Numakura, K., Kobayashi, M., Muto, Y., Sekine, Y., Takahashi, M., Kashima, S., Yamamoto, R., Koizumi, A., Nara, T., Saito, M., Narita, S., Nanjyo, H., Habuchi, T.(2020) First-line axitinib therapy is less effective in metastatic renal cell carcinoma with spindle histology. Sci. Rep., 10, 20089.
Hinata, N., Yonese, J., Masui, S., Nakai, Y., Shirotake, S., Tatsugami, K., Inamoto, T., Nozawa, M., Ueda, K., Etsunaga, T., Osawa, T., Uemura, M., Kimura, G., Numakura, K., Yamana, K., Miyake, H., Fukasawa, S., Ochi, K., Kaneko, H., Uemura, H. (2020) A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data. Int. J. Clin. Oncol., 25(8), 1533-1542.
Furuya, M., Iribe, Y., Nagashima, Y., Kambe, N., Ohe, C., Kinoshita, H., Sato, C., Kishida, T., Okubo, Y., Numakura, K., Nanjo, H., Nakaigawa, N., Makiyama, K., Hasumi, H., Iwashita, H., Ohta, J., Kitamura, H., Nakajima, T., Yoshida, T., Nakagawa, M., Tanaka, R., Yao, M.(2020)Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomas. J. Clin. Pathol., 73(12), 819-825.
Uemura, M., Tomita, Y., Miyake, H., Hatakeyama, S., Kanayama, HO., Numakura, K., Takagi, T., Kato, T., Eto, M., Obara ,W., Uemura, H., Choueiri, T. K., Motzer, R. J., Fujii, Y., Kamei, Y., Umeyama, Y., di, Pietro, A., Oya, M. (2020) Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101. Cancer Sci., 111(3), 907-923.
Nakajima, S., Inoue, T., Huang, M., Takayama, K., Kashima, S., Yamamoto, R., Koizumi, A., Nara, T., Numakura, K., Saito, M., Narita, S., Miura, M., Satoh, S., Habuchi, T. (2020) Does the Addition of Abiraterone to Castration Affect the Reduction in Bone Mineral Density? In Vivo., 34(6), 3291-3299.
Honma, N., Inoue, T., Tsuchiya, N., Koizumi, A., Yamamoto, R., Nara, T., Kanda, S., Huang, M., Numakura, K., Saito, M., Narita, S., Satoh, S., Habuchi, T. (2020) Prognostic value of plasminogen activator inhibitor-1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib. Health Sci. Rep., 3(4), 197.
Maeda, T., Nagano, S., Kashima, S., Terada, K., Agata, Y., Ichise, H., Ohtaka, M., Nakanishi, M., Fujiki, F., Sugiyama, H., Kitawaki, T., Kadowaki, N., Takaori-Kondo, A., Masuda, K., Kawamoto, H. (2020) Regeneration of Tumor-Antigen-Specific Cytotoxic T Lymphocytes from iPSCs Transduced with Exogenous TCR Genes. Mol. Ther. Methods Clin. Dev., 20, 250-260.
Hagimoto, H., Kashima, S., Doi, K., Nakayama, S., Sano, T., Imai, S., Yasufuku, T., Muramaki, M., Yamada, Y. (2020) Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma., IJU Case Rep., 3(6), 287-290.
Takamori, H., Kamba, T., Sumiyoshi, S., Tsuzuki, T., Kashima, S., Yoshino, T., Sano, T., Goto, T., Sawada, A., Akamatsu, S., Kobayashi, T., Yamasaki, T., Mizowaki, T., Ogawa, O., Inoue, T. (2020) Solitary recurrence of prostate cancer surrounded by seminal vesicle/vas deferens-like epithelium. IJU Case Rep., 3(5), 171-173.
Saito, R., Kobayashi, T., Kashima, S., Matsumoto, K., Ogawa, O. (2020) Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology. Int. J. Clin. Oncol., 25(5):831-841.
Matsumoto, H., Shiraishi, K., Azuma, H., Inoue, K., Uemura, H., Eto, M., Ohyama, C., Ogawa, O., Kikuchi, E., Kitamura, H., Shinohara, N., Takahashi, S., Tsuzuki, T., Nakagawa, M., Narumi, Y., Nishiyama, H., Habuchi, T., Hinotsu, S., Fujii, Y., Fujimoto, K., Fujimoto, H., Mizowaki, T., Matsuyama, H. (2020) Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: Revision working position paper. Int. J. Urol., 27(5):362-368.